153 related articles for article (PubMed ID: 7623442)
1. Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4-fumarylacetoacetate hydrolase deficiency.
Lloyd AJ; Gray RG; Green A
J Inherit Metab Dis; 1995; 18(1):48-55. PubMed ID: 7623442
[TBL] [Abstract][Full Text] [Related]
2. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
[TBL] [Abstract][Full Text] [Related]
3. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M
Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717
[TBL] [Abstract][Full Text] [Related]
4. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
Poudrier J; Lettre F; St-Louis M; Tanguay RM
Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
Grompe M; Lindstedt S; al-Dhalimy M; Kennaway NG; Papaconstantinou J; Torres-Ramos CA; Ou CN; Finegold M
Nat Genet; 1995 Aug; 10(4):453-60. PubMed ID: 7545495
[TBL] [Abstract][Full Text] [Related]
6. The enzyme defects in hereditary tyrosinaemia type I.
Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
[No Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.
Kim SZ; Kupke KG; Ierardi-Curto L; Holme E; Greter J; Tanguay RM; Poudrier J; D'Astous M; Lettre F; Hahn SH; Levy HL
J Inherit Metab Dis; 2000 Dec; 23(8):791-804. PubMed ID: 11196105
[TBL] [Abstract][Full Text] [Related]
8. Acute hereditary tyrosinaemia type I: clinical, biochemical and haematological studies in twins.
Gray RG; Patrick AD; Preston FE; Whitfield MF
J Inherit Metab Dis; 1981; 4(1):37-40. PubMed ID: 6785523
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight thiol content in glutathione synthetase-deficient human fibroblasts.
Debieu D; Deschavanne PJ; Malaise EP
Clin Chim Acta; 1987 Dec; 170(2-3):161-8. PubMed ID: 3436051
[TBL] [Abstract][Full Text] [Related]
10. Abnormal glutathione conjugation in patients with tyrosinaemia type I.
Mulders TM; Bergman DJ; Poll-The BT; Smit GP; Breimer DD; Mulder GJ; Duran M; Smeitink JA
J Inherit Metab Dis; 1997 Aug; 20(4):473-85. PubMed ID: 9266383
[TBL] [Abstract][Full Text] [Related]
11. S-Acetylglutathione normalizes intracellular glutathione content in cultured fibroblasts from patients with glutathione synthetase deficiency.
Okun JG; Sauer S; Bähr S; Lenhartz H; Mayatepek E
J Inherit Metab Dis; 2004; 27(6):783-6. PubMed ID: 15617191
[TBL] [Abstract][Full Text] [Related]
12. Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?
Ristoff E; Hebert C; Njålsson R; Norgren S; Rooyackers O; Larsson A
J Inherit Metab Dis; 2002 Nov; 25(7):577-84. PubMed ID: 12638941
[TBL] [Abstract][Full Text] [Related]
13. Nineteen-year follow-up of a patient with severe glutathione synthetase deficiency.
Atwal PS; Medina CR; Burrage LC; Sutton VR
J Hum Genet; 2016 Jul; 61(7):669-72. PubMed ID: 26984560
[TBL] [Abstract][Full Text] [Related]
14. Inborn errors in the metabolism of glutathione.
Ristoff E; Larsson A
Orphanet J Rare Dis; 2007 Mar; 2():16. PubMed ID: 17397529
[TBL] [Abstract][Full Text] [Related]
15. Type I hereditary tyrosinaemia: presentation of 11 cases.
Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
17. Physiological and pathological aspects of GSH metabolism.
Njålsson R; Norgren S
Acta Paediatr; 2005 Feb; 94(2):132-7. PubMed ID: 15981742
[TBL] [Abstract][Full Text] [Related]
18. The effects of early treatment of hereditary tyrosinemia type I in infancy by orthotopic liver transplantation.
Flye MW; Riely CA; Hainline BE; Sassa S; Gusberg RJ; Blakemore KJ; Barwick KW; Horwich AL
Transplantation; 1990 May; 49(5):916-21. PubMed ID: 2336709
[TBL] [Abstract][Full Text] [Related]
19. Diagnostics in patients with glutathione synthetase deficiency but without mutations in the exons of the GSS gene.
Njålsson R; Carlsson K; Winkler A; Larsson A; Norgren S
Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635114
[TBL] [Abstract][Full Text] [Related]
20. Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.
Kvittingen EA; Jellum E; Stokke O
Clin Chim Acta; 1981 Sep; 115(3):311-9. PubMed ID: 7296877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
